"Urgent Need for Long COVID Research Funding in the US Healthcare System"
A study published in Science found that individuals with long COVID symptoms at six months show dysregulation of the blood clotting and complement pathways, which may predict the persistence of symptoms. These findings could lead to the development of diagnostic tools and targeted therapies for long COVID. The study also suggests that therapies targeting these pathways could help alleviate long COVID symptoms, and antivirals targeting herpesvirus and SARS-CoV-2 may have the potential to ameliorate long COVID symptoms.